心理塑原体 tabernanthalog 诱导神经可塑性,而没有近距离的,即时的早期基因激活
Isak K Aarrestad1,2, Lindsay P Cameron1, Ethan M Fenton1,2
1Neuroscience Graduate Program, University of California, Davis, Davis, CA, USA.
Nature neuroscience
|August 5, 2025
概括
像tabernanthalog (TBG) 这样的非幻觉性心理塑料剂通过5-HT2A受体通路促进大脑的可塑性,类似于迷幻药,但没有幻觉效应. 这是TBG的TBG.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 非幻觉性心理塑物正在出现,作为治疗大脑疾病的迷幻药物更安全的替代品.
- 它们促进神经可塑性的确切机制,特别是5-HT2A受体和即时早期基因 (IEG) 激活的作用,仍然不清楚.
研究的目的:
- 调查5-HT2A受体和IEG激活是否调解非幻觉性心理塑物的神经可塑性影响.
- 与经典迷幻药相比,阐明涉及非幻觉性心理塑原体作用的特定生化途径.
主要方法:
- 在动物模型中利用药理和遗传工具.
- 研究了5-HT2A,TrkB,mTOR和AMPA受体通路的参与.
- 评估皮质螺旋生成,谷氨酸释放和IEG激活.
主要成果:
- 非幻觉性心理塑剂激活了与经典迷幻药相同的核心神经可塑性通路 (5-HT2A,TrkB,mTOR,AMPA).
- 由Tabernanthalog (TBG) 诱导的皮质螺旋生成对于其持续的抗抑郁药类行为效应至关重要.
- 与迷幻药不同,TBG不会立即触发谷氨酸激增或IEG激活.
结论:
- 非幻觉性心理塑剂可以通过与迷幻药物共享的途径促进皮质神经可塑性,但不诱导幻觉.
- 在TBG中没有直接的谷氨酸突发和IEG激活,这表明实现神经可塑性和治疗效果的替代机制.
相关概念视频
01:01Neuroplasticity
765
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
765
01:25Long-term Potentiation
2.9K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
2.9K